Evidence map›Paper›PMID 37170195›Full record

ArticleBMC genomics2023

Cis-regulatory atlas of primary human CD4+ T cells.

Kurtis Stefan, Artem Barski

Abstract read
In one paragraph

Article in BMC genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kurtis StefanDivision of Allergy & Immunology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7028, Cincinnati, OH, 45229-3026, USA.
Artem BarskiDivision of Allergy & Immunology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7028, Cincinnati, OH, 45229-3026, USA. Artem.Barski@cchmc.org.

Funding

Medical Scientist Training ProgramT32GM063483 · NIGMS · UNIVERSITY OF CINCINNATI · PI KHURANA HERSHEY, GURJIT K. · 2002 to 2022
$6.7M
An experimentally-refined, dynamic gene regulatory network model of T-cell memoryR01AI153442 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI BARSKI, ARTEM, MIRALDI, EMILY · 2021 to 2025
$3.2M
Death-Seq, a Method for Genome-wide Identification of Functional Silencer ElementsR21GM135634 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI BARSKI, ARTEM · 2020 to 2021
$437k
Silencer Control of T cell HomeostasisF30AI157421 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI STEFAN, KURTIS · 2021 to 2025
$174k
NIAID NIH HHS F30 AI157421NIAID NIH HHS R01 AI153442NIGMS NIH HHS GM063483NIGMS NIH HHS GM135634-01A1NIGMS NIH HHS R21 GM135634NIGMS NIH HHS T32 GM063483
6 · The paper itself

Abstract

Cis-regulatory elements (CRE) are critical for coordinating gene expression programs that dictate cell-specific differentiation and homeostasis. Recently developed self-transcribing active regulatory region sequencing (STARR-Seq) has allowed for genome-wide annotation of functional CREs. Despite this, STARR-Seq assays are only employed in cell lines, in part, due to difficulties in delivering reporter constructs. Herein, we implemented and validated a STARR-Seq-based screen in human CD4+ T cells using a non-integrating lentiviral transduction system. Lenti-STARR-Seq is the first example of a genome-wide assay of CRE function in human primary cells, identifying thousands of functional enhancers and negative regulatory elements (NREs) in human CD4+ T cells. We find an unexpected difference in nucleosome organization between enhancers and NRE: enhancers are located between nucleosomes, whereas NRE are occupied by nucleosomes in their endogenous locations. We also describe chromatin modification, eRNA production, and transcription factor binding at both enhancers and NREs. Our findings support the idea of silencer repurposing as enhancers in alternate cell types. Collectively, these data suggest that Lenti-STARR-Seq is a successful approach for CRE screening in primary human cell types, and provides an atlas of functional CREs in human CD4+ T cells.

Indexed as

CD4-Positive T-LymphocytesEnhancer Elements, GeneticNucleosomesCell DifferentiationCell LineHumansNucleosomesCD4Cis-Regulatory ElementsEnhancersNegative Regulatory ElementsSilencersSTARR-Seq

Identifiers

PMID37170195
PMCPMC10173520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.